848952-82-9

Basic information

• Product Name: 2-Pyridinecarboxylicacid,5-bromo-,hydrazide(9CI)
• Synonyms: 2-Pyridinecarboxylicacid,5-bromo-,hydrazide(9CI);5-bromopyridine-2-carbohydrazide
• CAS NO: 848952-82-9
• Molecular Formula: C₆H₆BrN₃O
• Molecular Weight: 216.04
• Product Categories: HYDRAZINE
• Mol File: 848952-82-9.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-Pyridinecarboxylicacid,5-bromo-,hydrazide(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Pyridinecarboxylicacid,5-bromo-,hydrazide(9CI)(848952-82-9)
• EPA Substance Registry System: 2-Pyridinecarboxylicacid,5-bromo-,hydrazide(9CI)(848952-82-9)

Safety Data

• Hazardous Substances Data: 848952-82-9(Hazardous Substances Data)

Upstream product

• 29682-15-3 methyl 5-bromopicolinate 
• 77199-09-8 5-bromo-pyridine-2-carboxylic acid ethyl ester 
• 67-56-1 methanol 
• 30766-11-1 5-bromoisonicotinic acid 

Relevant articles and documents

NOVEL 5H-PYRROLO[2,3-D]PYRIMIDIN-6(7H)-ONE DERIVATIVE

The invention of the present application provides a compound represented by Formula (I) or a salt thereof, which exhibits an inhibitory activity against at least one kinase selected from the group consisting of Akt kinase, Rsk kinase, and S6K kinase and/or a cell proliferation inhibiting effect and is useful as a prophylactic and/or therapeutic agent for diseases associated with the above-mentioned kinases, particularly cancer. [In the formula, R1 represents a 4- to 6-membered monocyclic unsaturated heterocyclic group which has 1 to 3 hetero atoms independently selected from N, S and O and may have a substituent; R2 represents a hydrogen atom or the like; R3, R4, and R5, may be the same as or different from one another and independently represent a hydrogen atom or the like; R6 represents a hydrogen atom or the like; R7 and R8, may be the same as or different from each other and independently represent a hydrogen atom or the like; X1 and X2 may be the same as or different from each other and independently represent N or CR9; R9 represents a hydrogen atom or the like; and X3 represents N or CH when the broken line (-----) represents a single bond, and represents C when a broken line indicates a double bond, wherein at least one of X1 or X2 represents N.]

UREA INHIBITORS OF MAP KINASES

Urea containing compounds that inhibit MAP kinases, pharmaceutical compositions including such compounds and methods for using these compounds to treat inflammatory diseases and cancer are described herein.

SUBSTITUTED TRIAZOLE DERIVATIVES AS OXYTOCIN ANTAGONISTS

The present invention relates to a class of substituted triazoles of formula (I) with activity as oxytoci antagonists, uses thereof, processes for the preparation thereof and compositions containing sai inhibitors. These inhibitors have utility in a variety of therapeutic areas including sexual dysfunction particularly premature ejaculation (P.E.).